Intratumoral injection of Ad-ISF35 (Chimeric CD154) breaks tolerance and induces lymphoma tumor regression.

about

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.

P2860

Q45854947-9866F668-4E66-4A34-8130-6D177838A932

P2860

Intratumoral injection of Ad-ISF35 (Chimeric CD154) breaks tolerance and induces lymphoma tumor regression.

Item

http://www.wikidata.org/entity/Q38941655

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Intratumoral injection of Ad-I ...... ces lymphoma tumor regression.

@en

type

Item

label

Intratumoral injection of Ad-I ...... ces lymphoma tumor regression.

@en

prefLabel

Intratumoral injection of Ad-I ...... ces lymphoma tumor regression.

@en

P1476

Intratumoral injection of Ad-I ...... uces lymphoma tumor regression

@en

P2093

Januario E Castro

http://www.w3.org/2001/XMLSchema#string

Robier Aguillon

http://www.w3.org/2001/XMLSchema#string

Thomas J Kipps

http://www.w3.org/2001/XMLSchema#string

P2860

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors

The role of CD40-CD154 interaction in cell immunoregulation

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia.

Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.

Gene immunotherapy of chronic lymphocytic leukemia: a phase I study of intranodally injected adenovirus expressing a chimeric CD154 molecule.

Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients.

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

P304

14-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2014.015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Johanna Melo-Cardenas

Mauricio Urquiza

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25382101

http://www.w3.org/2001/XMLSchema#string

P932

4303189

http://www.w3.org/2001/XMLSchema#string

Intratumoral injection of Ad-ISF35 (Chimeric CD154) breaks tolerance and induces lymphoma tumor regression.

about

P2860

P2860

Intratumoral injection of Ad-ISF35 (Chimeric CD154) breaks tolerance and induces lymphoma tumor regression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932